Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Curevac N.V.
(NQ:
CVAC
)
96.18
+1.88 (+1.99%)
Official Closing Price
Updated: 7:42 PM EST, Mar 1, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
741,800
Open
95.48
Bid (Size)
96.00 (2)
Ask (Size)
96.80 (1)
Prev. Close
94.30
Today's Range
94.98 - 97.00
52wk Range
36.15 - 151.80
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
CureVac to Participate in Upcoming Investor Conferences
February 18, 2021
From
ACCESSWIRE
CureVac Initiates Rolling Submission With European Medicines Agency for COVID-19 Vaccine Candidate, CVnCoV
February 12, 2021
From
ACCESSWIRE
Performance
YTD
+13.02%
+13.02%
1 Month
+1.72%
+1.72%
3 Month
-8.55%
-8.55%
6 Month
+74.62%
+74.62%
1 Year
+72.06%
+72.06%
More News
Read More
CureVac to Host Conference Call on COVID-19 Partnership Update on February 5, 2021
February 05, 2021
From
ACCESSWIRE
CureVac and UK Government to Collaborate on Development of Vaccines Against SARS-CoV-2 Variants
February 05, 2021
From
ACCESSWIRE
Johnson & Johnson's COVID-19 Vaccine Likely To Get EU Approval Early March: Bloomberg
February 26, 2021
Tags
News
CVAC
MRNA
From
Benzinga
CureVac Expands Lead RNA Cancer Program Phase 1 Trial in Advanced Melanoma
February 04, 2021
From
ACCESSWIRE
Moderna Raises 2021 Base COVID-19 Vaccine Production Plan To 700M Doses
February 25, 2021
Tags
GSK
JNJ
General
From
Benzinga
CureVac Announces Full Exercise of Underwriters' Option to Purchase Additional Common Shares
February 04, 2021
From
ACCESSWIRE
Moderna To Test New COVID-19 Vaccine Targeting South Africa Strain
February 25, 2021
Tags
Market News
NVAX
TEVA
From
Benzinga
FDA Says Conduct Smaller Trials To Test Vaccine Efficacy Against COVID Variants
February 23, 2021
Tags
MRNA
Benzinga
News
From
Benzinga
Sanofi/GlaxoSmithKline Initiate COVID-19 Vaccine Development After Setback
February 22, 2021
Tags
MRK
BNTX
Biotech
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.